Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit

Go back to Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit

Arrowhead Pharmaceuticals Corp (ARWR) Adds to Gains; Up 57%

September 6, 2018 10:44 AM EDT

Arrowhead Pharmaceuticals Corp (NASDAQ: ARWR) adds to early gains following data. Shares are now up 57%.

... More